Вирусология: В 3-х т. Том 1 - Филдс Б.Н.
ISBN 5-03-000283-9
Скачать (прямая ссылка):
101. Oldstone М. B. A., Sinha Y. N., Blount P., Tishon A., Rodriguez М., Von Wedel R., Lampert P. W. (1982). Virus-induced alterations in homeostasis: Alterations in differentiated functions of infected cells in vivo, Science, 218, 1125—1127.
102. Onodera Т., Ray U. R., Melez R. A., Suzuki H., Toniolo A., Notkins A. L. (1982). Virus-induced diabetes mellitus: Autoimmunity and polyendocrine disease prevented byimmunosupression, Nature (Lond.), 297, 66—68.
103. Onodera Т., Toniolo A., Ray U. R., Jenson A. B„ Rnazek R. A., Notkins A. L.
(1981). Virus-induced diabetes mellitus. XX. Polyendocrinopathy and autoimmunity, J. Exp. Med., 153, 1457—1473.
104. O’Shea S., Best J. M„ Banatvala J. E. (1983). Viremia, virus excretion, and antibody responces after challenge in volunteers with low levels of antibody to rubella virus, J. Inf. Cis., 148, 639—647.
105. Padgett B. L., Zurhein G. М., Walker D. L., Eckroade R. J., Dessel В. H. (1971). Cultivation of papova-like virus from human brain withprogressive multifocal leukoencephalopathy, Lancet, 1, 1257—1260.
106. Panusarn E., Stanley E. D., Dirda V., Rubenis M„ Jackson G. G. (1974). Prevention of illness from rhinovirus infection by a topicalinterferon inducer, N. Engl. J. Med., 291, 57—61.
107. Peiris J. S. М., Gordon S., Unkeless J. C., Porterfield J. S. (1981). Monoclonal anti-Fc receptor IgG blocks antibody enhancement of viral replication in macrophages, Nature (Lond.), 289, 189—191.
108. Peiris J. S. М., Porterfield J. S. (1979). Antibody-mediated enhancement of flavivirus replication in macropnage-like cell lines, Nature (lond.), 282, 509—511.
109. Plotch S. J., Bouloy М., Krug R. M. (1979). Transfer of 5'-terminal cap of globin mRNA to influenza viral complementary RNA during transcription in vitro, Proc. Natl. Acad. Sci. USA, 76, 1618—1622.
110. Prusiner S. B. (1982). Novel proteinaceous infectious particles cause scrapje, Science, 216, 136—144.
111. Reiss C. S., Schulman J. L. (1980). Cellular immune responses of mice to influenza virus vaccines, J. Immunol., 125, 2182—2188.
112. Reznikoff C„ Tegtmeyer P., Dohan C. Jr., Enders J. F. (1972). Isolation of AGMK cells partially resistant to SV40: Identification of the resistant step, Proc. Soc. Exp. Biol. Med., 141, 740—746.
113. Rose L. М., Goldman M„ Lambert P. Ii. (1982). Simultaneous induction of an idiotype, corresponding anti-idiotypic antibodies, and immune complexes during African trypanisomiasis in mice, J. Immunol., 128, 79—85.
114. RUbin D. H„ Fields B. N. (1980). The molecular basis of reovirus virulence: The role of the М2 gene, J. Exp. Med., 152, 853—868.
115. Rubin D. H„ Weiner H. L„ Fields B. N., Greene М. I. (1981). Immunologic tolerance after oral administration of reovirus: Requirement for two viral gene products for tolerance induction, J. Immunol., 127, 1697—1701.
116. Schied A., Choppin P. W. (1974). Identification of biological activities of paramyxovirus glycoproteins. Activation of cell fusion, hemolysis and infec-tivity by proteolytic cleavage of an inactive precursor protein of Sendai virus, Virology, 57, 475—490.
117. Schmaljohn A. L., Johnson E. D., Dalrymple J. М., Cole G. A. (1982). Nonneutralizing monoclonal antibodies can prevent lethal alphavirus encephalitis, Nature (Lond.), 297, 70—72.
118. Schmid D. S., Larsen H. S., Rouse В. T. (1982). Role of la antigen and secretory function of accessory cells in the induction of cytotoxic T lymphocyte responses against herpes simplex virus, Infect. Immunol, 37, 1138—1147.
119. Sethi К- K., Omata Y., Schneweis К. E. (1983). Protection of mice from fatal herpes simplex virus type I infection by adoptive transfer of cloned virus-specific and H2-restricted cytotoxic T lymphocytes, J. Gen. Virol., 64, 443—447.
120. Sever J. L., Zeman W„ eds. (1968). Conference on Measles Virus and Subacute Sclerosis Panencephalitis, Bethesda, Md., Sept. 13, 1967, Part 2, Neurology, 19(1), 30-51.
121. Shah К. V., Daniel R. W., Warszawski R. M. (1973). High prevalence of antibodies to BK. virus, an SV-40 related papovirus, in residents of Maryland, J. Inf. Dis., 128, 784—787.
122. Sharpe A. H„ Chen L. B., Fields B. N. (1982). The interaction of mammalian reoviruses with the cytoskeleton of monkey kidijey CV-1 cells, Virology, 120, 399—411.
123. Sharpe A. H., Fields B. N. (1981). Reovirus inhibition of cellular DNA synthesis: Role of the SI gene, J. Virol., 38, 389—392.
124. Sharpe A. H., Fields B. N. (1982). Reovirus inhibition of cellular RNA and protein synthesis: Role of the S4 gene, Virology, 122, 381—391.
124a. Sharpe A. H., Fields B. N. (1983). Pathogenesis of reovirus infection. In: The Reoviridae, ed. by W. K. Joklik, pp. 229—286, Plenum Press, New York.
J25. Shope R. E., Rozhon E. J., Bishop D. H. L. (1981). Role of the middlesized bunyavirus RNA segment in mouse virulence, Virology, 114, 273—276.
26. Simons М. J., Jack I. (1968). Lymphocyte viremia in congenital rubella, Lancet, 2, 953—954.
27. Spriggs D. R„ Bronson R. T„ Fields B. N. (1983). Hemagglutinin variants of reovirus type 3 have altered central nervous system tropism, Science. 220, 505—507.
